1. Clinical and pharmacologic experience with dibromodulcitol (NSC-104800), a new antitumour agent;Sellei;Cancer Chemother. Rep.,1969
2. Phase I study of dibromodulcitol (NSC-104800);Andrews;Cancer Chemother. Rep.,1971
3. Phase II study of dibromodulcitol (NSC-104800);Andrews;Cancer Chemother. Rep.,1974
4. Investigation in the distribution of 3H-1,6-dibromodulcitol and 3H-1,2-5,6-dianhydrodulcitol in the DNA, histone and non-histone fractions of t;Institóris,1972
5. The binding of in vivo administered dibromodulcitol to the DNA, histone and non-histone of Yoshida ascites tumour cells;Institóris;Z. Krebsforsch.,1974